The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Aminotransferase Levels and 20-Year Risk of Metabolic Syndrome, Diabetes, and Cardiovascular Disease
Open accessAbstract
Background & Aims Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of obesity and metabolic syndrome. Alanine aminotransferase (ALT) levels are used to detect NAFLD and have also been associated with increased risk for metabolic syndrome, diabetes mellitus and cardiovascular disease. We studied the relationship between ALT levels and these disorders in a long-term follow-up study. Methods Framingham Offspring Heart Study participants (n=2812, mean age 44 years, 56% women) were followed for the development of metabolic syndrome, diabetes, cardiovascular disease, and all-cause mortality using logistic regression (metabolic syndrome, diabetes) or Cox proportional hazards models (cardiovascular disease, all-cause mortality). Results Among individuals at baseline, per 1 standard deviation increase in log ALT level, there were increased odds of the development of metabolic syndrome (odds ratio 1.21, p<0.001) and diabetes (odds ratio 1.48, p<0.001) over 20 years of follow-up. These findings also applied to participants with ALT levels within the normal range (metabolic syndrome odds ratio 1.17, p=0.006; diabetes odds ratio 1.34, p=0.002). There was an increased risk of cardiovascular disease in age-sex adjusted models (hazard ratio 1.23, p<0.001), but this was attenuated in multivariable-adjusted models (hazard ratio 1.05, p=0.27); no association was observed for all-cause mortality. Aspartate aminotransferase levels were found to be associated with an increased risk of only diabetes. Conclusions Both normal and increased levels of ALT are associated with long-term development of multiple metabolic disorders. These results indicate the potential for ALT values as biomarkers for the risk for metabolic disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Thorelius, L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2006) · Hepatology · doi:10.1002/hep.21327 · Cited by 2,302
Epidemiological approaches to heart disease: the Framingham study
Dawber, T. R., Meadors, G. F., & Moore, F. E. (1951) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.41.3.279 · Cited by 2,148
AN INVESTIGATION OF CORONARY HEART DISEASE IN FAMILIES
KANNEL, W. B., FEINLEIB, M., McNAMARA, P. M., GARRISON, R. J., & CASTELLI, W. P. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112813 · Cited by 1,645
Updated definitions of healthy ranges for serum alanine aminotransferase levels
Prati, D., Taioli, E., Zanella, A., Torre, E. D., Butelli, S., Del Vecchio, E., Vianello, L., Zanuso, F., Mozzi, F., Milani, S., et al. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00006 · Cited by 1,445
The prevalence and etiology of elevated aminotransferase levels in the United States
Clark, J. (2003) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(03)00265-x · Cited by 1,360
Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy
Bellentani, S., Saccoccio, G., Masutti, F., Crocè, L. S., Brandi, G., Sasso, F., Cristanini, G., & Tiribelli, C. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-2-200001180-00004 · Cited by 1,265
Bedogni, G., Miglioli, L., Masutti, F., Tiribelli, C., Marchesini, G., & Bellentani, S. (2005) · Hepatology · doi:10.1002/hep.20734 · Cited by 1,263
Evaluation of Abnormal Liver-Enzyme Results in Asymptomatic Patients
Pratt, D. S., & Kaplan, M. M. (2000) · New England Journal of Medicine · doi:10.1056/nejm200004273421707 · Cited by 1,203
Mofrad, P., Contos, M. J., Haque, M., Sargeant, C., Fisher, R. A., Luketic, V. A., Sterling, R. K., Shiffman, M. L., Stravitz, R. T., & Sanyal, A. J. (2003) · Hepatology · doi:10.1053/jhep.2003.50229 · Cited by 1,201
Targher, G., Bertolini, L., Padovani, R., Rodella, S., Tessari, R., Zenari, L., Day, C., & Arcaro, G. (2007) · Diabetes Care · doi:10.2337/dc06-2247 · Cited by 992
Prediction of risk of liver disease by alcohol intake, sex, and age: A prospective population study
Becker, U., Deis, A., Sorensen, T. I., Gronbaek, M., Borch-Johnsen, K., Muller, C. F., Schnohr, P., & Jensen, G. (1996) · Hepatology · doi:10.1002/hep.510230513 · Cited by 851
Henry, R. J., Chiamori, N., Golub, O. J., & Berkman, S. (1960) · American Journal of Clinical Pathology · doi:10.1093/ajcp/34.4_ts.381 · Cited by 756
Vozarova, B., Stefan, N., Lindsay, R. S., Saremi, A., Pratley, R. E., Bogardus, C., & Tataranni, P. A. (2002) · Diabetes · doi:10.2337/diabetes.51.6.1889 · Cited by 717
ReviewIs Serum Gamma Glutamyltransferase a Marker of Oxidative Stress?
Lee, D.-H., Blomhoff, R., & Jacobs, D. R. (2004) · Free Radical Research · doi:10.1080/10715760410001694026 · Cited by 666
Drinking habits as cofactors of risk for alcohol induced liver damage
Bellentani, S., Saccoccio, G., Costa, G., Tiribelli, C., Manenti, F., Sodde, M., Croce’, L. S., Sasso, F., Pozzato, G., Cristianini, G., et al. (1997) · Gut · doi:10.1136/gut.41.6.845 · Cited by 630
Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease†
Villanova, N., Moscatiello, S., Ramilli, S., Bugianesi, E., Magalotti, D., Vanni, E., Zoli, M., & Marchesini, G. (2005) · Hepatology · doi:10.1002/hep.20781 · Cited by 629
Hyeon, C. K., Chung, M. N., Sun, H. J., Kwang, H. H., Kyu Oh, D., & Suh, I. (2004) · BMJ · doi:10.1136/bmj.38050.593634.63 · Cited by 600
Ruhl, C. E., & Everhart, J. E. (2003) · Gastroenterology · doi:10.1053/gast.2003.50004 · Cited by 596
AGA technical review on the evaluation of liver chemistry tests
Green, R. M., & Flamm, S. (2002) · Gastroenterology · doi:10.1053/gast.2002.36061 · Cited by 587
Targher, G., Bertolini, L., Poli, F., Rodella, S., Scala, L., Tessari, R., Zenari, L., & Falezza, G. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3541 · Cited by 574
AN APPROACH TO LONGITUDINAL STUDIES IN A COMMUNITY: THE FRAMINGHAM STUDY
Dawber, T. R., Kannel, W. B., & Lyell, L. P. (1963) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1963.tb13299.x · Cited by 560
Lee, D. S., Evans, J. C., Robins, S. J., Wilson, P. W., Albano, I., Fox, C. S., Wang, T. J., Benjamin, E. J., D’Agostino, R. B., & Vasan, R. S. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000251993.20372.40 · Cited by 530
Self-citationSchindhelm, R. K., Dekker, J. M., Nijpels, G., Bouter, L. M., Stehouwer, C. D. A., Heine, R. J., & Diamant, M. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.04.006 · Cited by 420
Liver Markers and Development of the Metabolic Syndrome
Hanley, A. J. G., Williams, K., Festa, A., Wagenknecht, L. E., D’Agostino, R. B., & Haffner, S. M. (2005) · Diabetes · doi:10.2337/diabetes.54.11.3140 · Cited by 419
Self-citationElevations in Markers of Liver Injury and Risk of Type 2 Diabetes
Hanley, A. J. G., Williams, K., Festa, A., Wagenknecht, L. E., D’Agostino, R. B., Kempf, J., Zinman, B., & Haffner, S. M. (2004) · Diabetes · doi:10.2337/diabetes.53.10.2623 · Cited by 385
Self-citationHepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV
Alberti, A., Morsica, G., Chemello, L., Cavalletto, D., Noventa, F., Pontisso, P., & Ruol, A. (1992) · The Lancet · doi:10.1016/0140-6736(92)92234-7 · Cited by 383
Abnormal Lipid and Glucose Metabolism in Obesity: Implications for Nonalcoholic Fatty Liver Disease
Parekh, S., & Anania, F. A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.055 · Cited by 340
Fraser, A., Longnecker, M. P., & Lawlor, D. A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.08.077 · Cited by 327
Ioannou, G. N., Boyko, E. J., & Lee, S. P. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.00341.x · Cited by 325
Non-alcoholic fatty liver: another feature of the metabolicsyndrome?
Cortez-Pinto, H., Camilo, M. E., Baptista, A., De Oliveira, A. G., & De Moura, M. C. (1999) · Clinical Nutrition · doi:10.1016/s0261-5614(99)80015-6 · Cited by 301
Serum aminotransferase concentration as evidence of hepatocellular damage
Kew, M. C. (2000) · The Lancet · doi:10.1016/s0140-6736(99)00219-6 · Cited by 300
Hepatic Enzymes, the Metabolic Syndrome, and the Risk of Type 2 Diabetes in Older Men
Wannamethee, S. G., Shaper, A. G., Lennon, L., & Whincup, P. H. (2005) · Diabetes Care · doi:10.2337/diacare.28.12.2913 · Cited by 274
Plasma adiponectin is decreased in nonalcoholic fatty liver disease
Pagano, C., Soardo, G., Esposito, W., Fallo, F., Basan, L., Donnini, D., Federspil, G., Sechi, L. A., & Vettor, R. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01821 · Cited by 256
Targher, G. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02025.x · Cited by 242
Chang, Y., Ryu, S., Sung, E., & Jang, Y. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2006.081257 · Cited by 229
Kunde, S. S., Lazenby, A. J., Clements, R. H., & Abrams, G. A. (2005) · Hepatology · doi:10.1002/hep.20818 · Cited by 212
Pathophysiological significance of adiponectin
Nishida, M., Funahashi, T., & Shimomura, I. (2007) · Medical Molecular Morphology · doi:10.1007/s00795-007-0366-7 · Cited by 169
Goland, S., Shimoni, S., Zornitzki, T., Knobler, H., Azoulai, O., Lutaty, G., Melzer, E., Orr, A., Caspi, A., & Malnick, S. (2006) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000225668.53673.e6 · Cited by 162
Siest, G., Schiele, F., Galteau, M. M., Panek, E., Steinmetz, J., Fagnani, F., & Gueguen, R. (1975) · Clinical Chemistry · doi:10.1093/clinchem/21.8.1077 · Cited by 155
Alanine Aminotransferase Levels: What's Normal?
Kaplan, M. M. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-1-200207020-00012 · Cited by 155
Prati, D., Capelli, C., Zanella, A., Mozzi, F., Bosoni, P., PAPPALETTERA, M., Zanuso, F., Vianello, L., Locatelli, E., Fazio, C., et al. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8536854 · Cited by 131
Endocannabinoids and Liver Disease. I. Endocannabinoids and their receptors in the liver
Mallat, A., & Lotersztajn, S. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00467.2007 · Cited by 113
Targher, G., Bertolini, L., Padovani, R., Poli, F., Scala, L., Zenari, L., Zoppini, G., & Falezza, G. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03349177 · Cited by 109
BMI vs. Waist Circumference for Identifying Vascular Risk
Freiberg, M. S., Pencina, M. J., D’Agostino, R. B., Lanier, K. J., Wilson, P. W. F., & Vasan, R. S. (2008) · Obesity · doi:10.1038/oby.2007.75 · Cited by 92
Self-citationMetabolic correlates of nonalcoholic fatty liver in women and men
Vega, G. L., Chandalia, M., Szczepaniak, L. S., & Grundy, S. M. (2007) · Hepatology · doi:10.1002/hep.21727 · Cited by 91
Ioannou, G. N., Weiss, N. S., Boyko, E. J., Kahn, S. E., & Lee, S. P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.004 · Cited by 78
Schindhelm, R. K., Dekker, J. M., Nijpels, G., Stehouwer, C. D. A., Bouter, L. M., Heine, R. J., & Diamant, M. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02100.x · Cited by 77
Metabolic syndrome and ALT: a community study in adult Koreans
Jeong, S.-K., Nam, H.-S., Rhee, J.-A., Shin, J.-H., Kim, J.-M., & Cho, K.-H. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802698 · Cited by 49
Association Among C-Reactive Protein, Fatty Liver Disease, and Cardiovascular Risk
Lizardi-Cervera, J., Chávez-Tapia, N. C., Pérez-Bautista, O., Ramos, M. H., & Uribe, M. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9262-6 · Cited by 39
Kim, H. C., Choi, K. S., Jang, Y. H., Shin, H. W., & Kim, D. J. (2006) · Yonsei Medical Journal · doi:10.3349/ymj.2006.47.4.542 · Cited by 37
Zanella, A., Conte, D., Prati, D., Mozzi, F., Capelli, C., Zanuso, F., Fraquelli, M., Bosoni, P., Vianello, L., PAPPALETTERA, M., et al. (1995) · Hepatology · doi:10.1002/hep.1840210404 · Cited by 27
Cited by
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
Targher, G., Day, C. P., & Bonora, E. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0912063 · Cited by 1,907
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Anstee, Q. M., Targher, G., & Day, C. P. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.41 · Cited by 1,747
Musso, G., Gambino, R., Cassader, M., & Pagano, G. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.518623 · Cited by 1,293
A position statement on NAFLD/NASH based on the EASL 2009 special conference
Ratziu, V., Bellentani, S., Cortez-Pinto, H., Day, C., & Marchesini, G. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.04.008 · Cited by 1,058
Epidemiology of Non-Alcoholic Fatty Liver Disease
Bellentani, S., Scaglioni, F., Marino, M., & Bedogni, G. (2010) · Digestive Diseases · doi:10.1159/000282080 · Cited by 1,026
Metadata
- Authors
- Goessling, W., Massaro, J. M., Vasan, R. S., D'Agostino, R. B., Ellison, R. C., & Fox, C. S.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2008-12
- Volume
- 135
- Issue
- 6
- Pages
- 1935-1944.e1
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2153413362
- Cited by
- 330
- References
- 55
- FWCI
- 15.33
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.